Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 10, No 1 (2014) MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT Abstract  similar documents
E. I. Trisvetova
"... of magnesium deficiency is realized using magnesium-containing drugs, for example magnesium orotate, having ..."
 
Vol 8, No 4 (2012) MAGNESIUM IN CLINICAL PRACTICE Abstract  similar documents
E. L. Trisvetova
"... the effectiveness of magnesium orotate for many cardiovascular diseases. ..."
 
Vol 4, No 5 (2008) MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... of orotic acid and magnesium orotate on cardiovascular system as well as therapeutic implementation ..."
 
Vol 11, No 2 (2015) MORPHOFUNCTIONAL CHARACTERISTICS OF FIBROBLASTS (MCCOY CELL LINE) CULTURED WITH MAGNESIUM PREPARATIONS Abstract  similar documents
L. V. Didenko, T. G. Borovaya, E. A. Kost, E. A. Ulubieva, A. V. Timofeeva, A. G. Avtandilov
"... Aim. To study the effect of magnesium orotate, magnesium/pyridoxine combination and magnesium ..."
 
Vol 9, No 4 (2013) EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY Abstract  similar documents
A. G. Avtandilov, K. M. Dzeranova, T. G. Borovaya, L. V. Didenko
"... contractility in patients with mitral valve prolapse before and after magnesium orotate course. Material ..."
 
Vol 8, No 6 (2012) THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY Abstract  similar documents
K. M. Dzeranova, A. G. Avtandilov, N. V. Vertkina
"... ) while taking magnesium orotate. Material and methods. Patients with MVP and phenotypic characteristics ..."
 
Vol 8, No 3 (2012) MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... At present experimental and clinical data confirming efficacy of magnesium-containing drugs ..."
 
Vol 12, No 1 (2016) Effect of magnesium on the cardiovascular system in women Abstract  PDF (Eng)  similar documents
E. A. Ulubieva, A. G. Avtandilov
"... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..."
 
Vol 3, No 3 (2007) COMPARATIVE EFFECTS OF MONOTHERAPY WITH MAGNESIUM AND COMBINED THERAPY WITH MAGNESIUM AND Β-BLOCKER ON PRIMARY MITRAL VALVE PROLAPSE WITH HEART RHYTHM DISORDERS Abstract  similar documents
E. G. Nurtdinova, A. N. Zakirova, T. B. Khairetdinova
"... were split into three groups. Group I (25 persons) received monotherapy with magnesium orotate ..."
 
Vol 13, No 1 (2017) CHANGE IN CONTENT OF GLYCOPROTEINS ON THE SURFACE OF ENDOTHELIAL CELL CULTURE EA.HY 926 AND INTIMA OF INTERNAL CAROTID ARTERIES UNDER THE INFLUENCE OF MAGNESIUM OROTATE Abstract  similar documents
L. V. Didenko, E. A. Ulubieva, T. G. Borovaya, A. G. Avtandilov, N. V. Shevlyagina, V. G. Zhukhovitsky, O. M. Grinkevich, M. V. Mezentseva
"... the influence of magnesium orotate. Material and methods. Endotheliocytes of cell culture EA.hy 926 were ..."
 
Vol 6, No 5 (2010) MAGNESIUM AND MITRAL VALVE PROLAPSE. EFFICACY AND THE POINTS OF APPLICATION Abstract  similar documents
A. G. Avtandilov, K. M. Dzeranova, A. A. Pukhaeva, E. D. Manizer
"... and international study data on magnesium orotate use in patients with MVP is presented. The results of their own ..."
 
Vol 7, No 4 (2011) FOCUS ON MAGNESIUM BASED DRUGS Abstract  similar documents
I. I. Esenova
"... Magnesium deficiency in the organism is one of the most common human deficiency states ..."
 
Vol 6, No 4 (2010) MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
A. V. Yezhov, L. T. Pimenov, M. A. Makarova, T. V. Savelyev
"... Aim. To study relationship of the clinical state and cardiac functional parameters with magnesium ..."
 
Vol 6, No 5 (2010) POTASSIUM AND MAGNESIUM DRUGS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN THE PRACTICE OF PRIMARY CARE PHYSICIAN Abstract  similar documents
A. M. Shilov, M. V. Melnik, A. O. Osiya, A. S. Lishuta
"... Role of magnesium and potassium deficiency in the development of cardiovascular diseases ..."
 
Vol 8, No 2 (2012) ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS Abstract  similar documents
A. V. Govorin, A. P. Filev
"... of different ASA formulations have been continuing. Magnesium hydroxide included in combined medicine ..."
 
Vol 8, No 4 (2012) ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? Abstract  similar documents
I. V. Zhirov
"... – 58. 10. Rosenfeldt F. Metabolic supplementation with orotic acid and magnesium orotate. Cardiovasc ..."
 
Vol 4, No 5 (2008) EDITORIAL Abstract  similar documents
Р. Г. Оганов
"... - торы обсуждают механизмы воздействия оротовой кислоты и оротата магния на сердечно-сосудистую систему и ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... in group A1 with type 2 and type 3 of LV remodeling reduced less (2%, p=0.02 and 4%, p=0.04, respectively ..."
 
Vol 6, No 3 (2010) THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova
"... , respectively, р=0,03). Negative relations between aldosterone and estradiol levels (r=-0,3; p=0,04 ..."
 
Vol 5, No 5 (2009) EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev
"... (p=0,034), received furosemide (p=0.004) and digoxin (p=0,004). They had significant increase in end ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"... conventionally managed. Kaplan-Meier curves revealed that risk of CHF decompensation (р=0.001), mortality (р=0.04 ..."
 
Vol 12, No 3 (2016) ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS Abstract  PDF (Eng)  similar documents
R. A. Gajfulin, A. N. Sumin, O. G. Arhipov
"... correlated with age: At (p=0.004); Et/At (p=0.001); Vpt (p=0.002) and e't/a't ratio (p=0.004). Conclusion ..."
 
Vol 14, No 6 (2018) Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety Abstract  PDF (Eng)  similar documents
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
"... safety criteria is [0,02-0,38] for QT prolongation and [-0,04-0,04] for bradycardia. Conclusion. Safety ..."
 
Vol 4, No 1 (2008) COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky
"... ) in high-frequency (HF: 0,15-0,4 Hz) and low-frequency (LF: 0,04-0,15 Hz) ranges was calculated as well ..."
 
Vol 4, No 3 (2008) COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva
"... with enalapril (р=0,04). Brain natriuretic peptide and von Willebrand factor levels decreased more significantly ..."
 
Vol 12, No 5 (2016) Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis Abstract  similar documents
M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov
"... =0.04). Serum endothelin level was 1.8 times lower in men who received statins, compared with men ..."
 
Vol 13, No 3 (2017) EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina
"... in the sacubitril/valsartan group on Day 1 after 6 hours (50%, p=0.004) and subsequent-samples up to 12 hours ..."
 
Vol 13, No 6 (2017) RISK FACTORS OF ARTERIAL HYPERTENSION IN ORGANIZED COHORT OF MALE EMPLOYEES OF THE MACHINE BUILDING PLANT Abstract  similar documents
A. N. Britov, S. A. Tjupaeva, N. A. Eliseeva, A. N. Meshkov, A. D. Deev
"... .3%, respectively; p<0.04), that appears to be evidence of early organ disorders. OF were found more often ..."
 
Vol 14, No 2 (2018) NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY Abstract  similar documents
S. G. Shulkina, Е. N. Smirnova
"... .3; 60.0] ng/ml (р=0.04) and IL-18 – from 0.33 [0.18; 0.41] to 0.21 [0.14; 0.43] pg/ml (р=0.04). Greater ..."
 
Vol 6, No 2 (2010) THE MODERN ASPECTS OF CLOPIDOGREL USE Abstract  similar documents
E. N. Dankovtseva, D. A. Zateyshchikov
"... больные получали комбинированный пре- парат (АСК + магния гидроксид) в дозе 300 мг при по- ступлении, а ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... primary PCI group (1.0% vs 0.2%, p=0.04; after correction protocol and dose reduction by half ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... .5 pg/ml vs 24.1±14.8 pg/ml, р=0.03; 63.7±54.8 pg/ml vs 50.7±40.8 pg/ml, р=0.04, respectively ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... ) as compared to the control group (RR 0.09; 95%CI 0.01-0.9; p=0.04). Conclusion. Treatment with FA, B and B ..."
 
Vol 8, No 2 (2012) SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY Abstract  similar documents
E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa
"... 14.2% in groups 1 and 2, respectively (p=0.004). High risk of death was defined 3 times more often ..."
 
Vol 6, No 5 (2010) INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  PDF (Eng)  similar documents
E. N. Golovenko, D. A. Napalkov, V. A. Sulimov
"... . Mean TrI and myoglobin concentrations equaled 0.04 [0.02; 0.06] ng/ml and 62.95 [35.86; 77.28] μg/l ..."
 
Vol 6, No 3 (2010) CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
V. N. Larina, B. Ya. Bart, V. G. Larin
"... ,041), had diabetes more often (p=0,004, χ2=8,01) in comparison with non anemic patients. Deficiency of iron ..."
 
Vol 5, No 6 (2009) COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
V. M. Provotorov, M. L. Gluhovsky
"... because of antiarrhythmic effect loss was also revealed (20.0% vs 46.1%, p=0.004). A number of patients ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... .13–0.68; p=0.004) and hyperuricemia (OR=0.23; 95%CI 0.10–0.50; p<0.001) were shown to be independent ..."
 
Vol 12, No 6 (2016) EFFECT OF AMLODIPINE ON CIRCADIAN RHYTHM OF BLOOD PRESSURE IN HYPERTENSIVE FEMALE PATIENTS WITH DIFFERENT PSYCHO-EMOTIONAL BACKGROUND Abstract  similar documents
V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, A. I. Vinogradov
"... and from 38.5±10.2 to 95.3±14.7 (p=0.004) in the Group 2. Be- sides increase in load by reduced SBP during ..."
 
Vol 12, No 6 (2016) EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev
"... -vaccinated group (28 and 442; р<0.0001). The vaccinated group had fewer CSD worsening cases per patient (p=0.04 ..."
 
Vol 13, No 5 (2017) RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM ROUTINE CONTROL TO EFFECTIVE MANAGEMENT Abstract  similar documents
N. А. Nikolayev, Y. P. Skirdenko, S. S. Bunova, A. V. Ershov
"... ; p=0.002 at the 150th week; p=0.004 at the 200th week). By the end of the study in the patient ..."
 
Vol 15, No 3 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with cerebrovascular diseases and a 1.4-fold increase in the risk of ischemic stroke (p=0.004), atheromatosis ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... was significantly higher(OR=2.88, р=0.0001). Permanent AF significantly increased the risk of stroke (OR=2.07, р=0.04 ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... .824, p=0.004] and RAAS inhibitors [OR=0.710; CI=0.512-0.986, p=0.040] prior to the development of acute ..."
 
Vol 8, No 1 (2012) GENDER DISTINCTIONS OF MICROALBUMINURIA AND ITS RELATION TO INTRARENAL HEMODYNAMIC AND LEPTIN LEVEL IN ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, J. N. Rodionova
"... in females with MAU was higher than this in female patients without MAU: 103.5±38.7 vs 76.7±46.4 ng/ml (p=0.04 ..."
 
Vol 6, No 6 (2010) HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY Abstract  similar documents
V. V. Mazur, A. M. Kalinkin, E. S. Mazur
"... at any CHF stage in PICS patients was significantly higher than this in DCM patients (1.48±0.04 and 1 ..."
 
Vol 7, No 4 (2011) PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Abstract  similar documents
A. L. Komarov, O. O. Shahmatova, D. V. Rebrikov, D. Yu. Trophimov, T. I. Kotkina, T. A. Ilyushenko, A. D. Deev, E. P. Panchenko
"... .63 times (95% CI 1.2-2.3, р=0.006) and 1.37 times (95% CI 1.001-1.89, р=0.04), respectively. Such genetic ..."
 
Vol 13, No 5 (2017) COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES Abstract  similar documents
A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash
"... .9% of women and 7.4% of men (p=0.031), while the history of MI was more often found in male patients (p=0.004 ..."
 
Vol 13, No 5 (2017) INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION Abstract  similar documents
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash
"... with the ticagrelor group (p=0.04 and p=0.01, respectively). Conclusion. When clopidogrel is replaced with ticagrelor ..."
 
Vol 13, No 6 (2017) FACTORS INFLUENCING ON THE MORTALITY IN PATIENTS WITH OBLITERATING DISEASES OF LOWER LIMB ARTERIES Abstract  similar documents
A. N. Sumin, M. A. Kosova, Ju. D. Medvedeva, A. V. Shcheglova, O. I. Rajh, S. A. Makarov, G. V. Artamonova, L. S. Barbarash
"... .031), atherosclerosis of two or more arterial basins ≥50% (OR 3.43, 95% CI 3.46-5.52; p=0.004), the presence ..."
 
Vol 15, No 3 (2019) Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus Abstract  similar documents
Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
"... (11.15 [10.05; 12.35] vs 10.15 [8.83; 11.83] m/s; p=0.04) were found as well as significantly lower (p ..."
 
Vol 11, No 4 (2015) EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION Abstract  similar documents
I. G. Kirillova, D. S. Novikova, T. V. Popkova, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, K. A. Kasumova, S. A. Vladimirov, M. A. Kanonirova, G. L. Lukina, A. A. Novikov, E. N. Aleksandrova, D. E. Karateev, E. L. Nasonov
"... with the improved LV diastolic function [E/A LV and ΔESR (r=-0,3; p<0,04), E/A LV and CRP (r=-0,2; p<0.05), A LV ..."
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... ,928], р<0,004), смерти от всех причин (ОШ: 0,908 [95% ДИ 0,845-0,975], р=0,008), впервые возникшей СН (OШ ..."
 
Vol 5, No 6 (2009) MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION (ENDING) Abstract  similar documents
Frans Van de Werf, Jeroen Bax, Amadeo Betriu, Carina Blomstrom-Lundqvist, Filippo Crea, Volkmar Falk, Gerasimos Filippatos, Keith Fox, Kurt Huber, Adnan Kastrati, Annika Rosengren, P. Gabriel Steg, Marco Tubaro, Freek Verheugt, Franz Weidinger, Michael Weis, M. O. Evseev
"... уровни электролитов, магния, стимуляция изопротеренолом или лидокаином I C Обсудить неотложную ..."
 
Vol 7, No 1 (2011) ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? Abstract  similar documents
L. N. Malay
"... ) с гидроксидом магния, периндоприл 4 мг однократно вечером. Динамика показателей липидного спектра у ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... ,18) 0,92 (0,79-1,07) нд Смерть от инсульта 119 (0,04) 98 (0,03) 1,21 (0,84-1,74) нд Любой инсульт 655 (0 ..."
 
Vol 4, No 3 (2008) HYPERMOBILITY SYNDROME: CLINICAL MANIFESTATIONS, DIFFERENTIAL DIAGNOSIS, THERAPY APPROACHES Abstract  similar documents
N. A. Shostak, N. G. Pravdyuk
"... метаболизма соедини- тельной ткани отводится магнию. В условиях его не- достатка происходит усиление ..."
 
Vol 9, No 4 (2013) ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES Abstract  similar documents
E. N. Dankovtseva
"... ,0003), как и высокие – 300-1200 мг/сут (ОР=0,3; 95% ДИ 0,47-0,86; р=0,004). Снижение частоты развития ..."
 
Vol 6, No 4 (2010) EFFECTS OF ACUTE PHYSICAL EXERCISE OF VARYING INTENSITY ON LIPID METABOLISM IN MIDDLE AGED MEN Abstract  similar documents
G. E. Roytberg, I. D. Slastnikova, O. Ju. Dmitrieva, T. I. Ushakova
"... глюкозооксидантным мето- дом, предварительно осаждая сыворотку крови хло- ристым магнием. Определение ХС ЛПНП ..."
 
Vol 13, No 6 (2017) ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Akimova, V. P. Voronina, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, L. A. Sokolova, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
"... recommendations than patients, not visiting the treating physician (p=0.004). Сonclusion. The levels of overall ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE Abstract  similar documents
V. N. Drozdov, V. A. Kim
"... ,2 мг неабсорбируемого антацида — гидроксида магния. Особенностью препарата кар- диомагнил является ..."
 
Vol 12, No 3 (2016) CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 2 Abstract  PDF (Eng)  similar documents
I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov
"... =0.43(р<0.001) SBP / САД r=0.25 (p=0.003) r=0.21 (р=0.011) r=0.38(р<0.001) r=0.23(р=0.004) DBP / ДАД ..."
 
Vol 6, No 6 (2010) THERAPY FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS WHO PRESENT LATE OR ARE INELIGIBLE FOR REPERFUSION Abstract  similar documents
M. Cohen, C. Boiangiu, M. Abidi, N. S. Chipigina
"... лечении только аспирином, p=0,04), но при этом наблюдалось значимое учащение больших кро- 0 5 10 15 ..."
 
Vol 13, No 4 (2017) FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION Abstract  similar documents
V. E. Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... ,07±0,14* 1,02±0,21* 0,922±0,04 *p<0,05, **p<0,01, ***p<0,001 по сравнению с контролем; ††p <0,01 по ..."
 
Vol 9, No 6 (2013) DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi
"... =0.04). Repeated RVG in the second group of patients showed similar results. Target VR achievement ..."
 
Vol 12, No 5 (2016) Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
"... mononitrate, and intravenous magnesium sulphate in 58050 patients with sus- pected acute myocardial infarction ..."
 
Vol 3, No 3 (2007) EDITORIA Abstract  similar documents
R. G. Oganov
"... продемонстри- рованы преимущества комбинированной терапии препаратом магния и бета-блокатором у больных ..."
 
Vol 6, No 4 (2010) GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY Abstract  similar documents
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev
"... ,2, 95% ДИ 0,04–0,7). Стратификация риска с помощью стресс-тестов позволяет выделить подгруппу пациен ..."
 
Vol 2, No 1 (2006) COMMENTS ON GUIDELINES OF THE TASK FORCE ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY OF EUROPEAN SOCIETY OF CARDIOLOGY  similar documents
R. I. Striyk
"... внутри- венным введением солей магния усиливается угнете- ние сократимости миокарда. В третьем ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... the range of 0,003-0,04 Hz (activity of a number of neurohumoral parameters); LF, ms2 - low frequency ..."
 
Vol 12, No 3 (2016) EFFECT OF GENDER DIFFERENCES ON THE EFFICACY AND SAFETY OF REPERFUSION THERAPY OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (DATA OF RETROSPECTIVE SINGLE-CENTER STUDY – HOSPITAL PERIOD) Abstract  PDF (Eng)  similar documents
D. B. Nemik, G. V. Matyushin, A. V. Protopopov, A. V. Shulmin, S. A. Ustyugov
"... =0,004) [28, 29]. Изучение ТЛТ у женщин носит ограниченный ха- рактер. В 6 клинических ..."
 
Vol 5, No 5 (2009) INFLUENCE OF BRONCHOLYTIC THERAPY ON VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
Kh. Kh. Shugushev, M. V. Gurizheva, V. M. Vasilenko
"... ,27±0,11a 2,47±0,05c 2,00 1,71±0,05 0,65±0,08a 2,22±0,11c 0,65±0,08aс Q Y 1,85±0,04 1,00 2,14±0,04c 2 ..."
 
Vol 5, No 6 (2009) INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS Abstract  similar documents
A. A. Usanova, A. A. Aleksandrovsky, A. V. Zorkina, O. M. Kiselеv
"... /кг Каталаза, мкКат/л⋅с 0,12±0,001 0,064±0,002a 0,1±0,005ab 0,008±0,003ab 0,079±0,004ab 0,08±0,004ab ..."
 
Vol 1, No 3 (2005) PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE Abstract  similar documents
V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova
"... исходно 0,65±0,02 0,68±0,02 0,53±0,05 0,56±0,04 0,65±0,06 0,63±0,03 0,56±0,03 0,56±0,05 через 6 мес 0 ..."
 
Vol 13, No 2 (2017) ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC Abstract  PDF (Eng)  similar documents
E. V. Stepina, M. M. Loukianov, M. A. Bichurina, E. N. Belova, E. V. Kudryashov, Ju. V. Uzkov, S. A. Boytsov
"... - ke including warfarin in 26.3% of cases (p=0.98) and NOAC in 11.6% (p=0.04). Among patients with stro ..."
 
Vol 4, No 1 (2008) EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE Abstract  similar documents
S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash
"... (на 25,9%, p=0,02), пульсового давления днем (на 13%, p=0,04) и пульсового давления ночью (на 29%, p<0 ..."
 
Vol 3, No 4 (2007) THE ALGORITHMIC MODEL OF LABORATORY DIAGNOSTICS OPTIMIZATION Abstract  similar documents
G. I. Nazarenko, O. V. Andropova
"... лабораторной диагностики лия и магния. Осмотический диурез обычно развива- ется при глюкозурии и диабетическом ..."
 
Vol 6, No 6 (2010) INDEX OF THE PAPERS PUBLISHED IN THE “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” JOURNAL IN 2010 Abstract  similar documents
"... , М. И, Макарова, Т. В. Савельева - Обмен магния и кли- нико-функциональные характеристики больных ..."
 
Vol 2, No 4 (2006) CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY Abstract  similar documents
R. I. Striuk
"... внимание на категорическое противопока- зание одновременного назначения сульфата магния и других препаратов ..."
 
Vol 8, No 5 (2012) TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE Abstract  similar documents
M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn
"... ,27; р=0,04). Схожие результаты были получены при использовании в качестве анти- генной детерминанты ..."
 
Vol 10, No 4 (2014) TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE Abstract  similar documents
O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov
"... .1111/1471-0528.12737. [Epub ahead of print] 13. Schauf B., Becker S., Abele H. et al. Effect of magnesium ..."
 
Vol 3, No 3 (2007) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... early oral captopril, oral mononitrate, and intraveno- us magnesium sulphate in 58050 patients with ..."
 
Vol 6, No 5 (2010) THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? Abstract  similar documents
S. Yu. Martsevich
"... magnesium sulphate in 58050 patients with sus- pected acute myocardial infarction. Lancet 1995; 345(8951 ..."
 
Vol 5, No 3 (2009) REPERFUSION THERAPY IN ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION Abstract  similar documents
A. L. Alyavi, B. A. Alyavi
"... ,51±0,06 0,51±0,06 РА ТК, м/с 0,43±0,04 0,43±0,04 0,43±0,04 Vmax ЛА, м/с 0,73±0,06 0,75±0,07 0,77±0 ..."
 
Vol 7, No 4 (2011) ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID Abstract  similar documents
I. N. Bokarev, L. V. Popova
"... , Аспирин- кардио и др.), а также комбинации аспирина с невса- сывающимся антацидом (гидроксидом магния ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... , содержащих 75 и 150 мг АСК и 15,2 мг неабсор- бируемого антацида магния гидрооксида. Защитное действие ..."
 
Vol 10, No 3 (2014) ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova
"... на фоне лечения; ∆%=-26,1) и в моче (0,46±0,04 пг/мл исходно vs 0,11±0,01 пг/мл через 24 нед терапии ..."
 
Vol 1, No 2 (2005) MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION Abstract  similar documents
F. Van de Werf, D. Ardissino, A. Betriu, D. Cokkinos, E. Falk, K. Fox, D. Julian, M. Lengyel, F.J. Neumann, W. Ruzyllo, C. Thygesen, R. Underwood, A. Vahanian, F. Verheugt, W. Wijns
 
Vol 12, No 1 (2016) Leonid B. Lazebnik is 75 years Abstract  similar documents
Editorial article
"... кандидатскую диссертацию на тему «Лечение нарушений сердечного ритма аспарагинатом калия и магния (клинико ..."
 
Vol 9, No 3 (2013) CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION Abstract  similar documents
N. V. Furman, S. S. Shmatova
"... и магния у пациентов, принимающих ме- дикаменты, которые могут влиять на уровень калия и магния, в ..."
 
Vol 2, No 1 (2006) SUPRAVENTRICULAR RHYTHM DISTURBANCES TREATMENT WITH ANTIARHYTHMIC DRUG III CLASS NIBENTAN IN PATIENTS WITH ISCHEMIC HEART DISEASE (EXPERIMENTAL, CLINICAL AND MORPHOLOGICAL EVIDENCES) Abstract  similar documents
I. A. Latfullin, R. F. Gaifullina
"... удлине- ния интервала QT внутривенно вводили 10 мл 25% раствора сульфата магния. однократно. В случае ис ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... магния, выводящиеся из организма [3, 4]. Активация данных рецепторов в условиях раз- личных ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... Влияние CYP3A4 и гена CYP2C19 на активность тромбоцитов compared with the carriers of GG (p=0.04) or AA ..."
 
Vol 10, No 4 (2014) DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... - tients without IHD were prescribed aspirin more sel- dom – in 33.3% (5 of 15 cases), p=0.04; clopidogrel ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... . Эпидемиологические исследования сви- детельствуют, что ежегодный прирост ТКИМ сонных ар- терий составляет от 0,004 до ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... / ТГ, ммоль/л 1.3 0.9 1.8 1.1 0.004 LDL, mmol/l / ХС ЛПНП, ммоль/л 4.0 1.1 4.4 1.4 0.020 Atherogenic ..."
 
Vol 11, No 2 (2015) LOW SODIUM DIET: PROS AND CONS Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... ;22(11):763-70. 29. Larsson S.C., Virtanen M.J., Mars M., et al. Magnesium, Calcium, Potassium, and ..."
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... intravenous magnesium sulphate in 58050 patients with suspect acute myocardial infarction. Lancet 1995; 346 ..."
 
Vol 9, No 2 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspect ..."
 
1 - 100 of 345 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)